|
National Stock Number(NSN): 6505-00-268-9280 (6505002689280, 002689280)
| NIIN: |
00-268-9280 |
Item Name: |
POTASSIUM CHLORIDE,LYSINE HYDROCHLORIDE,AND POTASSIUM BICARBONATE EFFERVESCENT TABLETS FOR ORAL SOLUTION |
INC: |
40742
|
| FSC: |
6505
|
Assignment Date: |
Jul-22-1973 |
CRIT: |
X |
IIG: |
40742 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
3004.90.9265 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
KL0RVESS |
17632
|
SANDOZ CONSUMER HEALTH CARE GROUP |
H |
3 |
1 |
4 |
75 |
3 |
D |
|
|
|
|
|
NDC0043-0100-84 |
17632
|
SANDOZ CONSUMER HEALTH CARE GROUP |
H |
3 |
2 |
4 |
75 |
4 |
D |
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DN |
S9M |
Y |
|
M |
U |
1 |
N |
$3.50 |
PG |
|
9L----- |
Oct-01-1989 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
0.913 GRAMS L-LYSINE MONOHYDROCHLORIDE ACTIVE INGREDIENT AND 0.500 GRAMS POTASSIUM BICARBONATE ACTIVE INGREDIENT AND 1.125 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
STRIP |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
6.000 TABLETS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
5 |
| FEAT |
SPECIAL FEATURES |
COATING FEATURE:FILM,ENTERIC;ADMINISTRATION:ORAL SOLUBLE; |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|